SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
| (Mark One) | ||||
| x |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||
|
|
|
| ||
| For the quarterly period ended March 31, 2003 | ||||
|
|
|
| ||
| OR | ||||
|
|
|
| ||
| o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||
|
|
|
| ||
| For the transition period from ___________________ to___________________ | ||||
|
| ||||
| Commission file number 0-16752 | ||||
|
| ||||
| MEDSTONE INTERNATIONAL, INC. | ||||
| | ||||
| (Exact name of registrant as specified in its charter) | ||||
|
|
|
| ||
| DELAWARE |
|
66-0439440 | ||
| |
|
| ||
| (State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) | ||
|
|
|
| ||
| 100 Columbia, Suite 100, Aliso Viejo, California |
|
92656 | ||
| |
|
| ||
| (Address of principal executive offices) |
|
(Zip code) | ||
|
|
|
| ||
| Registrants telephone number, including area code: (949) 448-7700 | ||||
|
| ||||
| Not Applicable | ||||
| | ||||
| (Former name, former address and former fiscal year, if changed, since last report) | ||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
| Yes x |
No o |
The number of shares of the Common Stock of the registrant outstanding as of May 1, 2003 was 3,758,220
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).
| Yes o |
No x |
The number of shares of the Common Stock of the registrant outstanding as of June 30, 2002 was 3,920,020. The number of shares voting and non-voting Common Stock held by non-affiliates on such date was 3,827,312 with an approximate aggregate market value of $19,327,926.
MEDSTONE INTERNATIONAL, INC.
INDEX TO FORM 10-Q
|
|
|
Page No. |
|
|
|
|
| PART I. FINANCIAL INFORMATION |
| |
|
|
|
|
| Item 1. |
Financial Statements: |
|
|
|
|
|
|
|
Consolidated Balance Sheets March 31, 2003 (Unaudited) and December 31, 2002 |
3 |
|
|
|
|
|
|
Consolidated Statements of Income Three Months Ended March 31, 2003 and 2002 (Unaudited) |
4 |
|
|
|
|
|
|
Consolidated Statement of Stockholders Equity Three Months Ended March 31, 2003 (Unaudited) |
5 |
|
|
|
|
|
|
Consolidated Statements of Cash Flows Three Months Ended March 31, 2003 and 2002 (Unaudited) |
6 |
|
|
|
|
|
|
7 | |
|
|
|
|
| Item 2. |
Managements Discussion and Analysis of Financial Condition and Results of Operations |
11 |
| Item 3. | Market Risk Changes | |
| Item 4. |
| |
|
| ||
|
|
|
|
| Item 1. |
15 | |
|
|
|
|
| Item 2. |
15 | |
|
|
|
|
| Item 3. |
15 | |
|
|
|
|
| Item 4. |
15 | |
|
|
|
|
| Item 5. |
15 | |
|
|
|
|
| Item 6. |
15 | |
|
|
|
|
| 16 | ||
|
|
| |
|
| ||
- 2 -
MEDSTONE INTERNATIONAL, INC.
CONSOLIDATED BALANCE SHEETS
|
|
|
March 31, |
|
December 31, |
| ||
|
|
|
|
|
|
| ||
|
|
|
|
|
(Unaudited) |
| ||
| ASSETS |
|
|
|
|
|
|
|
| Current assets: |
|
|
|
|
|
|
|
| Cash and cash equivalents |
|
$ |
1,940,332 |
|
$ |
2,050,466 |
|
| Short-term investments held to maturity |
|
|
4,341,831 |
|
|
4,323,491 |
|
| Accounts receivable, less allowance for doubtful accounts of $931,769 and $871,769 at March 31, 2003 and December 31, 2002, respectively |
|
|
3,289,013 |
|
|
3,720,410 |
|
| Income taxes receivable |
|
|
589,375 |
|
|
589,375 |
|
| Inventories, less allowance for inventory obsolescence of $716,700 and $642,712 at March 31, 2003 and December 31, 2002, respectively |
|
|
6,405,923 |
|
|
6,440,304 |
|
| Deferred tax assets |
|
|
955,877 |
|
|
955,877 |
|
| Prepaid expenses and other current assets |
|
|
1,007,585 |
|
|
647,169 |
|
|
|
|
|
|
|
|
|
|
| Total current assets |
|
|
18,529,936 |
|
|
18,727,092 |
|
|
|
|
|
|
|
|
|
|
| Buildings, property and equipment, at cost: |
|
|
|
|
|
|
|
| Building |
|
|
359,324 |
|
|
359,324 |
|
| Lithotripters |
|
|
13,750,702 |
|
|
13,524,440 |
|
| Equipment, furniture and fixtures |
|
|
3,387,807 |
|
|
3,368,431 |
|
| Leasehold improvements |
|
|
177,318 |
|
|
177,318 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,675,151 |
|
|
17,429,513 |
|
| Less accumulated depreciation and amortization |
|
|
(13,989,559 |
) |
|
(13,602,049 |
) |
|
|
|
|
|
|
|
|
|
| Net property and equipment |
|
|
3,685,592 |
|
|
3,827,464 |
|
|
|
|
|
|
|
|
|
|
| Goodwill, net |
|
|
2,929,897 |
|
|
2,929,897 |
|
| Investment in unconsolidated subsidiaries |
|
|
794,744 |
|
|
734,083 |
|
| Net investment in sale-type lease |
|
|
119,514 |
|
|
169,428 |
|
| Other assets, net |
|
|
86,964 |
|
|
93,243 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
26,146,647 |
|
$ |
26,481,207 |
|
|
|
|
|
|
|
|
|
|
| LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
| Current liabilities: |
|
|
|
|
|
|
|
| Accounts payable |
|
$ |
715,166 |
|
$ |
900,295 |
|
| Accrued expenses |
|
|
311,168 |
|
|
267,229 |
|
| Accrued payroll expenses |
|
|
344,302 |
|
|
366,855 |
|
| Customer deposits |
|
|
120,187 |
|
|
75,175 |
|
| Deferred revenue |
|
|
469,581 |
|
|
494,704 |
|
|
|
|
|
|
|
|
|
|
| Total current liabilities |
|
|
1,960,404 |
|
|
2,104,258 |
|
|
|
|
|
|
|
|
|
|
| Deferred tax liabilities |
|
|
639,224 |
|
|
639,224 |
|
| Minority interest |
|
|
395,606 |
|
|
423,224 |
|
| Deferred rent |
|
|
79,135 |
|
|
82,613 |
|
| Commitments and contingencies (Notes 7 and 8) |
|
|
|
|
|
|
|
| Stockholders equity: |
|
|
|
|
|
|
|
| Common stock - $.004 par value, 20,000,000 shares authorized, 5,742,670 shares issued at both March 31, 2003 and December 31, 2002 |
|
|
22,971 |
|
|
22,971 |
|
| Additional paid-in capital |
|
|
19,646,388 |
|
|
19,646,388 |
|
| Accumulated earnings |
|
|
16,228,627 |
|
|
16,350,292 |
|
| Accumulated other comprehensive loss |
|
|
(59,999 |
) |
|
(22,054 |
) |
| Treasury stock, at cost, 1,984,450 at both March 31, 2003 and December 31, 2002, respectively |
|
|
(12,765,709 |
) |
|
(12,765,709 |
) |
|
|
|
|
|
|
|
|
|
| Total stockholders equity |
|
|
23,072,278 |
|
|
23,231,888 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
26,146,647 |
|
$ |
26,481,207 |
|
|
|
|
|
|
|
|
|
|
See accompanying notes
- 3 -
MEDSTONE INTERNATIONAL, INC.
CONSOLIDATED STATEMENTS OF INCOME
Three months ended March 31, 2003 and 2002
(Unaudited)
|
|
|
2003 |
|
2002 |
| ||
|
|
|
|
|
|
| ||
| Revenues: |
|
|
|
|
|
|
|
| Procedures, maintenance fees and fee-for-service |
|
$ |
4,068,423 |
|
$ |
4,337,435 |
|
| Net equipment sales |
|
|
719,127 |
|
|
1,896,443 |
|
| Interest income |
|
|
40,501 |
|
|
82,123 |
|
|
|
|
|
|
|
|
|
|
| Total revenues |
|
|
4,828,051 |
|
|
6,316,001 |
|
| Costs and operating expenses: |
|
|
|
|
|
|
|
| Cost of procedures and maintenance fees |
|
|
2,231,259 |
|
|
2,426,949 |
|
| Cost of equipment sales |
|
|
795,404 |
|
|
1,474,909 |
|
| Research and development |
|
|
409,061 |
|
|
260,939 |
|
| Selling |
|
|
617,033 |
|
|
812,215 |
|
| General and administrative |
|
|
802,119 |
|
|
817,490 |
|
|
|
|
|
|
|
|
|
|
| Total costs and operating expenses |
|
|
4,854,876 |
|
|
5,792,502 |
|
|
|
|
|
|
|
|
|
|
| Operating income (loss) |
|
|
(26,825 |
) |
|
523,499 |
|
| Other expense (income) |
|
|
23,820 |
|
|
(1,887 |
) |
| Minority interests: |
|
|
|
|
|
|
|
| Minority interest in subsidiaries income |
|
|
170,381 |
|
|
170,019 |
|
| Equity in loss (income) from unconsolidated subsidiary |
|
|
(69,161 |
) |
|
30,359 |
|
|
|
|
|
|
|
|
|
|
| Total minority interest |
|
|
101,220 |
|
|
200,378 |
|
|
|
|
|
|
|
|
|
|
| Income (loss) before provision for income taxes |
|
|
(151,865 |
) |
|
325,008 |
|
| Provision for (benefit from) income taxes |
|
|
(30,200 |
) |
|
157,800 |
|
|
|
|
|
|
|
|
|
|
| Net income (loss) |
|
$ |
(121,665 |
) |
$ |
167,208 |
|
|
|
|
|
|
|
|
|
|
| Net income (loss) per share: |
|
|
|
|
|
|
|
| Basic |
|
$ |
(.03 |
) |
$ |
.04 |
|
|
|
|
|
|
|
|
|
|
| Diluted |
|
|
N/A |
|
$ |
.04 |
|
|
|
|
|
|
|
|
|
|
| Number of shares used in the computation of earnings (loss) per share: |
|
|
|
|
|
|
|
| Basic |
|
|
3,758,220 |
|
|
3,954,553 |
|
|
|
|
|
|
|
|
|
|
| Diluted |
|
|
N/A |
|
|
3,954,553 |
|
|
|
|
|
|
|
|
|
|
See accompanying notes.
- 4 -
MEDSTONE INTERNATIONAL, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY
|
|
|
Common Stock |
|
|
Additional |
|
Accumulated |
|
Accumulated |
|
Treasury |
|
Total |
| ||||||||
| | ||||||||||||||||||||||
| Number of |
|
Amount | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at December 31, 2002 |
|
|
3,758,220 |
|
$ |
22,971 |
|
$ |
19,646,388 |
|
$ |
16,350,292 |
|
$ |
(22,054 |
) |
$ |
(12,765,709 |
) |
$ |
23,231,888 |
|
| Net loss |
|
|
|
|
|
|
|
|
|
|
|
(121,665 |
) |
|
|
|
|
|
|
|
(121,665 |
) |
| Other comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unrealized loss on foreign currency translation, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(37,945 |
) |
|
|
|
|
(37,945 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total comprehensive loss |
|
|
|
|
|
|
|
|
|
|||||||||||||